Avanafil
目录号: A12619
PDE5 抑制剂
Avanafil 是一种用于治疗勃起功能障碍的 PDE5 抑制剂。
Discription | Avanafil is a PDE5 Inhibitor for the Treatment of Erectile Dysfunction | ||
---|---|---|---|
Targets |
|
目录号 | A12619 |
---|---|
分子式 | C23H26ClN7O3 |
分子量 | 483.95 |
CAS号 | 330784-47-9 |
SMILES | COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl |
其他名称 | TA 1790 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 84 mg/mL (173.57 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.66 mL | 103.32 mL | 206.63 mL |
0.5 mM | 4.13 mL | 20.66 mL | 41.33 mL |
1 mM | 2.07 mL | 10.33 mL | 20.66 mL |
5 mM | 0.41 mL | 2.07 mL | 4.13 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2